| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 3 | |
| #2 | Brazil | 2 | |
| #3 | Canada | 2 | |
| #4 | EPO (European Patent Office) | 2 | |
| #5 | Republic of Korea | 2 | |
| #6 | United States | 2 | |
| #7 | Australia | 1 | |
| #8 | China | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Microorganisms | |
| #3 | Medical preparations | |
| #4 | Peptides | |
| #5 | Climate change adaptation technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Sarry Emeline | 13 |
| #2 | Vaillant Renaud | 13 |
| #3 | Bauche Cecile | 10 |
| #4 | Mourlane Frederic | 9 |
| #5 | Mourlane Frédéric | 4 |
| #6 | Bauche Cécile | 3 |
| #7 | Renaud Vaillant | 2 |
| #8 | Frederic Mourlane | 2 |
| #9 | Cecile Bauche | 2 |
| #10 | Emeline Sarry | 2 |
| Publication | Filing date | Title |
|---|---|---|
| WO2019106432A2 | Viral vector constructs for expression of genetic adjuvants mimicking cd40 signaling | |
| KR20190121289A | Viral Vector Constructs for Expression of Gene Adjuvant Activating CD40 and STING Pathways | |
| EP3545097A1 | Viral vector constructs for expression of genetic adjuvants activating the sting pathway |